The following are important resources on the status of vaccine coverage esp in LMICs and links to how coverage is assessed.
1. WHO provides guidance on methods for measuring immunization coverage through surveys:
2. Cutts FT et al. Monitoring vaccination coverage: Defining the role of surveys.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4967442/pdf/main.pdf
3. The 2021 WHO fact sheet on immunization coverage:
https://www.who.int/news-room/fact-sheets/detail/immunization-coverage
4. The latest (2022) WHO/UNICEF estimates of national immunization coverage (WUENIC):
https://data.unicef.org/topic/child-health/immunization/
5. Technet-21 document summarising progress and challenges with achieving universal immunisation coverage in 2020. Estimates are as of July 15, 2021 and includes data reported as of July 6, 2021.
6. Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1
https://www.thelancet.com/action/showPdf?pii=S0140-6736%2821%2900984-3
7. GAVI – stories on routine immunization and how countries are improving coverage
https://www.gavi.org/vaccineswork/tag/routine-immunisation?page=0
8. Child vaccination in sub-Saharan Africa: Increasing coverage addresses inequalities.
https://www.sciencedirect.com/science/article/pii/S0264410X21014390?via%3Dihub
9. Root causes of low vaccination coverage and under-immunization in Sub-Saharan Africa.
Singh K, Kaur N, Prabhu A. Combating COVID-19 Crisis using Artificial Intelligence (AI) Based Approach: Systematic Review. Curr Top Med Chem. 2024 Feb 2. doi: 10.2174/0115680266282179240124072121. Epub ahead of print. PMID: 38318824. DOI: 10.2174/0115680266282179240124072121
MacDonald SE, Kenzie L, Letendre A, Bill L, Shea-Budgell M, Henderson R, Barnabe C, Guichon JR, Colquhoun A, Ganshorn H, Bedingfield N, Vandenboogaard PD, Bednarczyk RA, Glaze S, Nelson G. Barriers and supports for uptake of human papillomavirus vaccination in Indigenous people globally: A systematic review. PLOS Glob Public Health. 2023 Jan 6;3(1):e0001406. DOI: 10.1371/journal.pgph.0001406
Huang Y, Zhang Y, Seaton KE, De Rosa S, Heptinstall J, Carpp LN, Randhawa AK, McKinnon LR, McLaren P, Viegas E, Gray GE, Churchyard G, Buchbinder SP, Edupuganti S, Bekker LG, Keefer MC, Hosseinipour MC, Goepfert PA, Cohen KW, Williamson BD, McElrath MJ, Tomaras GD, Thakar J, Kobie JJ; NIAID HIV Vaccine Trials Network (HVTN) 073/South African AIDS Vaccine Initiative (SAAVI) 102, HVTN 086/SAAVI 103, HVTN 094, HVTN 097, HVTN 098, HVTN 100, HVTN 105, HVTN 111, and HVTN 205 Protocol Leadership Teams. Baseline host determinants of robust human HIV-1 vaccine-induced immune responses: A meta-analysis of 26 vaccine regimens. EBioMedicine. 2022 Oct;84:104271. DOI: 10.1016/j.ebiom.2022.104271
Zibako P, Hlongwa M, Tsikai N, Manyame S, Ginindza TG. Mapping Evidence on Management of Cervical Cancer in Sub-Saharan Africa: Scoping Review. Int J Environ Res Public Health. 2022 Jul 28;19(15):9207. DOI: 10.3390/ijerph19159207
Krauss SR, Barbateskovic M, Klingenberg SL, Djurisic S, Petersen SB, Kenfelt M, Kong Z, Jakobsen JC, Gluud C. Aluminium adjuvants versus placebo or no intervention in vaccine randomised clinical trials: a systematic review with meta-analysis and Trial Sequential Analysis. BMJ Open. 2022 Jun 23;12(6):e058795. DOI: 10.1136/bmjopen-2021-058795
Braunfeld JB, Carson HN, Williams SR, Schwartz LM, Neuzil KM, Ortiz JR. Clinical endpoints to inform vaccine policy: A systematic review of outcome measures from pediatric influenza vaccine efficacy trials. Vaccine. 2022 Jul 30;40(32):4339-4347. doi: 10.1016/j.vaccine.2022.06.028. Epub 2022 Jun 16. PMID: 35717265. (NOT OA)
.